Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Renewal without Stem Cells01:23

Tissue Renewal without Stem Cells

2.2K
After cellular or tissue damage, the resident stem cells present in the human body can locally repair and regenerate the damaged tissue or organ. However, even though some tissues do not have stem cells, they can repair and regenerate with the help of pre-existing cells. For example, beta cells of the pancreas and hepatocytes of the liver can divide to renew and regenerate the tissue. Here, both cell division and cell death are well regulated by homeostasis.
However, failure of such a system...
2.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

1.6K
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long-Term Survival of Hypoimmune Allogeneic Islets without Immunosuppression.

The New England journal of medicine·2026
Same authorSame journal

Ethical Implementation of Organ Donation Following Medical Assistance in Dying: Recommendations of the Ethics Committee of the Transplantation Society.

Transplantation·2026
Same author

Ethical Considerations in Islet Xenotransplantation.

Xenotransplantation·2026
Same author

What's Hot and What's New in Xenotransplantation From the Young Investigator Committee of the IXA-Basic and Translational Science.

Xenotransplantation·2026
Same author

OPTN/SRTR 2024 Annual Data Report: Pancreas.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same author

The Gut-Brain Axis: A Case Report of Transanal Extrusion of a Ventriculoperitoneal Shunt and Literature Review.

Cureus·2026

Related Experiment Video

Updated: Feb 23, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

β Cell Replacement Therapy: The Next 10 Years.

Christian Schuetz1, Takayuki Anazawa2, Sarah E Cross3

  • 1Center for Transplantation Sciences, Transplant Surgery Division, Department of Surgery. Massachusetts General Hospital, Boston, MA.

Transplantation
|September 9, 2017
PubMed
Summary
This summary is machine-generated.

Pancreas and islet transplantation offer improved insulin independence but face donor shortages. Future solutions like xenotransplantation and stem cell-derived beta cells are being explored for unlimited cell sources.

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.3K
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.7K

Related Experiment Videos

Last Updated: Feb 23, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice
10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.3K
A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform
09:35

A High-content In Vitro Pancreatic Islet β-cell Replication Discovery Platform

Published on: July 16, 2016

11.7K

Area of Science:

  • Endocrinology
  • Transplantation immunology
  • Regenerative medicine

Background:

  • Pancreas and islet transplantation have achieved significant success in diabetes management, with high rates of insulin independence.
  • Current transplantation strategies are limited by the scarcity of donor organs and tissues.
  • Advances in immunosuppression, donor selection, and surgical techniques have driven progress in transplantation outcomes.

Purpose of the Study:

  • To summarize a debate among young investigators on the future of beta cell replacement therapies.
  • To explore potential solutions to donor scarcity in beta cell replacement.
  • To compare the prospects of pancreas transplantation, islet transplantation, xenotransplantation, and stem cell-derived beta cells.

Main Methods:

  • The study summarizes arguments presented at the 15th International Pancreas and Islet Transplant Association Congress and the 26th international congress of The Transplant Society.
  • Young investigators debated the future landscape of beta cell replacement therapies.
  • Key modalities discussed include pancreas transplantation, islet transplantation, xenotransplantation, and stem cell-derived beta cells.

Main Results:

  • Pancreas and islet transplantation show high short-term (1-year: ~85%) and moderate long-term (5-year: ~50%) insulin independence rates.
  • Xenotransplantation presents a theoretically unlimited islet source but faces immune rejection challenges.
  • Stem cell-derived beta cells offer another unlimited source, pending functional advancements.

Conclusions:

  • The future of beta cell replacement will likely involve a combination of improved existing methods and novel approaches.
  • Addressing donor scarcity through xenotransplantation and stem cell therapies is crucial for long-term diabetes management.
  • Continued research and innovation are essential to overcome current limitations in beta cell replacement strategies.